1. Home
  2. OBIO vs DOYU Comparison

OBIO vs DOYU Comparison

Compare OBIO & DOYU Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • OBIO
  • DOYU
  • Stock Information
  • Founded
  • OBIO 2017
  • DOYU 2014
  • Country
  • OBIO United States
  • DOYU China
  • Employees
  • OBIO N/A
  • DOYU N/A
  • Industry
  • OBIO Medicinal Chemicals and Botanical Products
  • DOYU Computer Software: Programming Data Processing
  • Sector
  • OBIO Health Care
  • DOYU Technology
  • Exchange
  • OBIO Nasdaq
  • DOYU Nasdaq
  • Market Cap
  • OBIO 291.7M
  • DOYU 311.0M
  • IPO Year
  • OBIO N/A
  • DOYU 2019
  • Fundamental
  • Price
  • OBIO $8.08
  • DOYU $16.79
  • Analyst Decision
  • OBIO Strong Buy
  • DOYU Sell
  • Analyst Count
  • OBIO 2
  • DOYU 4
  • Target Price
  • OBIO $17.00
  • DOYU $7.03
  • AVG Volume (30 Days)
  • OBIO 244.6K
  • DOYU 542.1K
  • Earning Date
  • OBIO 08-08-2024
  • DOYU 08-12-2024
  • Dividend Yield
  • OBIO N/A
  • DOYU N/A
  • EPS Growth
  • OBIO N/A
  • DOYU N/A
  • EPS
  • OBIO N/A
  • DOYU N/A
  • Revenue
  • OBIO $2,216,000.00
  • DOYU $706,531,667.00
  • Revenue This Year
  • OBIO $17.90
  • DOYU N/A
  • Revenue Next Year
  • OBIO $10.51
  • DOYU $2.27
  • P/E Ratio
  • OBIO N/A
  • DOYU N/A
  • Revenue Growth
  • OBIO N/A
  • DOYU N/A
  • 52 Week Low
  • OBIO $4.22
  • DOYU $6.29
  • 52 Week High
  • OBIO $11.69
  • DOYU $18.40
  • Technical
  • Relative Strength Index (RSI)
  • OBIO 55.30
  • DOYU 70.29
  • Support Level
  • OBIO $7.71
  • DOYU $16.05
  • Resistance Level
  • OBIO $8.87
  • DOYU $17.06
  • Average True Range (ATR)
  • OBIO 0.51
  • DOYU 0.78
  • MACD
  • OBIO -0.05
  • DOYU -0.13
  • Stochastic Oscillator
  • OBIO 45.52
  • DOYU 35.63

About OBIO Orchestra BioMed Holdings Inc.

Orchestra BioMed Holdings Inc is a biomedical innovation company accelerating high-impact technologies to patients through risk-reward sharing partnerships. Its partnership-enabled business model focuses on forging strategic collaborations with medical device companies to drive the global commercialization of the products it develops. The company's flagship product candidates include BackBeat Cardiac Neuromodulation Therapy (CNT) for the treatment of hypertension and Virtue Sirolimus AngioInfusionBalloon (SAB) for the treatment of atherosclerotic artery disease.

About DOYU DouYu International Holdings Limited ADS

DouYu International Holdings Ltd is a game-centric live streaming platform in China and a pioneer in the eSports value chain. The company operates its platform on both PC and mobile apps, through which users can enjoy immersive and interactive games and entertainment live streaming. It generates revenues through live streaming and advertisement.

Share on Social Networks: